GaBI Online reached over 5,690,668 page views and 3,874,350 total visits by 2024/Q3
Stay connected with these healthcare professionals every day — Contact us for an information pack
Last update: 6 October 2024
GaBI Online is a reliable, critical and independent source of information on off-patent medicines since 2009. It offers you the possibility of reaching thousands of healthcare professionals, who visit our news platform on a daily basis in their need to stay informed on the rapid developments of the science and research of generic and biosimilar medicines.
GaBI Online subscribers are professionals from government, research, academic, and scientific institutes; biopharmaceutical/ biotechnology organizations; (bio)pharmaceutical companies; legal and patent companies; API manufacturers; CROs; as well as individual healthcare providers like physicians, pharmacists and researchers.
GaBI Online’s visitor data recorded steady increase. Contributing to the growth of page views and visits is that GaBI Online offers enriched and solidly-researched editorial content which continually attracts new visitors, with a monthly average of 67% visits by new visitors and 33% visits by an established group of loyal (returning) visitors. This reflects the stability of GaBI Online visitors.
Promote your company and service to decision makers through GaBI Online weekly eNewsletter, which offers access to a large network of highly educated and affluent audience with the focus interest in generic and biosimilar medicines.
GaBI Online offers a wide variety of powerful advertising opportunities to deliver your message effectively. We work closely with clients to build a package that meets their individual needs.
We limit the number of ad positions in each eNewsletter so that subscribers never experience ad 'clutter' and our advertisers are showcased to their individual marketing and targeting requirements.
Contact us to benefit from the unique advertising opportunity of reaching this premier audience.
Page views by No. of pages
Average page views per website visit in 2023: 1.6
Time spent in seconds
Average time spent on website in 2023: 60 seconds
In 2023, GaBI Online Visitors are from over 194 countries
What we achieved in 2023
- Total visits in 2023: 370,033
- Total page views in 2023: 393,919
- Average total visitors per month in 2023: 30,836+
- Average page views per website visit: 1.6
- Average time spent on website: 60 seconds
- GaBI Online Google page rank is #4 since January 2012
- Total number of subscribers: 15,850
- Average new subscribers per month in 2023: 49+
- GaBI Online Weekly E-newsletter highest open rate in 2023: 31.8%; average 11.6%†
- Email blast (advertiser) highest open rate in 2023: 27.4%†
†list industry average: 22.5%
By end of 2023/Q4, GaBI Online achieved
- GaBI Online hosts over 5,258+ articles on generics and biosimilars since 2009
- 3,109,798 total visits
- 2,175,120 absolute unique visitors
- 5,431,372 total page views
- Average active users per month (2023/Q4): 24,208
Unique features and benefits:
- Reliable and independent source with diversified editorial content on off-patent medicines
- Comprehensive repository (hub) of scientific reports on generics and biosimilars, worldwide guidelines, policies and legislations, and country specific data
- High percentage of new visitors (69%) and loyal (returning) visitors (31%)
- Regular communication to healthcare professionals from all sectors of the healthcare industry worldwide
Advertising opportunities:
- Banner advertising
- Sponsored sections - interview, company profile, product news, sponsored links
- E-marketing
Contact us for further information, or fill in your contact details below and you will be sent a complete media kit with GaBI Online advertising opportunities and rates, as well as relevant market data.
